Hepatoprotectors of vegetable origin in therapy of drug-induced hepatitis
https://doi.org/10.21518/2079-701X-2016-14-48-51
Abstract
The objective of the work is evaluation of effectiveness of Silimar drug in therapy of patients with drug-induced hepatitis (DIH) with cholestasis syndrome who received chemical therapy for oncologic pathology. Design: comparative non-randomized study. Materials and methods: results of a month-long therapy of 30 DIH patients with cholestasis syndrome who received chemical therapy for oncologic pathology were analyzed with evaluation of US study of the abdominal cavity organs US study, values of blood biochemistry and clinical manifestations. The criteria of effectiveness of Silimar action was the dynamics of the abovestated indicators (at the initial time point and in a month after the therapy).
About the Authors
O. N. Minushkin
Central State Medical Academy of RF President Affairs Management, Moscow
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
I. V. Zverkov
Central State Medical Academy of RF President Affairs Management, Moscow
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
A. I. Ostrovskaya
Central State Medical Academy of RF President Affairs Management, Moscow
Russian Federation
Russian Federation
References
1. Лечение основных проявлений болезней печени. Клиническая фармакология и терапия, 1996, 1: 4-8. / Therapy of major hepatic disease manifestations. Klinicheskaya Farmakologia I Terapia, 1996, 1: 4-8.
2. Минушкин О.Н. Некоторые гепатопротекторы в лечении заболеваний печени. Лечащий врач, 2002, 6: 55-58. / Minushkin O.N. Some hepatoprotectors in therapy of hepatic diseases. Lechaschiy Vrach, 2002, 6: 55-58.
3. Минушкин О.Н., Логинов С.И., Масловский Л.В., Зверков И.В. Возможность клинико-лабораторной оценки фиброза печени в условиях поликлиники. Терапевтический архив, 2007, 1: 19-23. / Minushkin O.N., Loginov S.I., Maslovsky L.V., Zverkov I.V. Possibility of clinical and laboratory evaluation of liver fibrosis in polyclinical conditions. Terapevtichesky Arkhiv, 2007, 1: 19-23.
4. Минушкин О.Н., Масловский Л.В. Лечение жировой болезни печени различной этиологии. Рассмотрение современных рекомендаций. Эффективная фармакотерапия (гастроэнтерология), 2012, 3: 14-20. / Minushkin O.N., Maslovsky L.V. Therapy of the liver fatty diseases of various etiology. Consideration of modern recommendations. Effektivnaya Farmakoterapia (Gastroenterologia), 2012, 3: 14-20.
5. Маев И.В., Самсонов А.А., Андреев Д.Н. Болезни желудка. Москва, 2015: 15-24. / Maev I.V., Samsonov A.A., Andreev D.N. Diseases of stomach. Moscow, 2015: 15-24.
6. Пасечников В.Д., Чуков С.З., Котелевец С.М. Профилактика рака желудка на основе эрадикационной терапии предопухолевых заболеваний. Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2003, 4: 11-19. / Pasechnikov V.D., Chukov C.Z., Kotelevets S.M. Prevention of gastric cancer on the basis of eradiation therapy of pre-cancer diseases. Rossiysky Zhurnal Gastroenterologii, Gepatologii, Koloproktologii, 2003, 4: 11-19.
Review
For citations:
Minushkin ON, Zverkov IV, Ostrovskaya AI. Hepatoprotectors of vegetable origin in therapy of drug-induced hepatitis. Meditsinskiy sovet = Medical Council. 2016;(14):48-51. (In Russ.) https://doi.org/10.21518/2079-701X-2016-14-48-51
Views:
664
Email this article 